查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2014299

白内障手术设备市场：按产品类型、技术和最终用户划分 - 2026-2032年全球市场预测

Cataract Surgery Devices Market by Product Type, Technology, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年白内障手术设备市场价值为 85 亿美元，预计到 2026 年将成长至 91.8 亿美元，复合年增长率为 8.36%，到 ​​2032 年将达到 149.3 亿美元。

主要市场统计数据
基准年 2025 85亿美元
预计年份：2026年 91.8亿美元
预测年份 2032 149.3亿美元
复合年增长率 (%) 8.36%

在临床创新、医疗保健服务环境变化和采购要求的背景下，白内障手术器材的发展趋势。

白内障手术器材在外科创新、人口需求和医疗服务体系发展三者交汇处占据着至关重要的地位。过去十年，该领域已从依赖传统的超音波乳化术和单焦点人工水晶体发展到如今拥有更多选择，旨在改善屈光效果、缩短恢復时间并创造更安全的手术环境。这些进步得益于成像技术、雷射精度、人工水晶体设计以及旨在保护眼组织和优化术中操作的耗材等方面的同步发展。

高精度雷射、多样化的人工水晶体结构和分散式医疗服务如何重新定义临床实务和供应商策略。

在白内障手术设备领域，正在发生多项变革性变化，这些变化正在重塑临床方案、供应商策略和投资重点。首先，精准引导的飞秒雷射系统正在改变手动操作的角色，它能够实现高度可重复的囊膜切开术和精准的弧形切口，进而影响高端人工水晶体的选择以及对屈光矫正效果的预期。同时，人工水晶体的设计也从单焦点光学结构向景深扩展、多焦点、散光矫正和高度非球面等多种结构发展，从而扩大了目标患者群体，并引发了关于高端医疗服务报销问题的更多讨论。

检验2025 年美国关税措施对营运和采购的影响，以及这些措施对医疗设备采购和临床部署的连锁反应。

美国近期针对2025年实施的关税措施以及更广泛的贸易政策环境，对白内障手术医疗设备的供应链产生了显着的连锁反应，促使製造商和医疗服务提供者重新评估筹资策略和成本结构。由于许多医疗设备和关键零件的生产地点分散，进口关税的增加引发了一系列连锁反应。一些供应商暂时自行承担成本以维持市场进入，另一些供应商则将采购转向国内或免税供应商，还有一些供应商加快了关键子组件的本地化生产。因此，采购计画和供应商谈判中现在都加入了更明确的紧急条款和短期风险评估。

详细的細項分析显示产品类型、技术工作流程和医疗保健环境如何决定部署模式、培训需求和采购优先顺序。

关键的细分洞察揭示了产品设计、手术技术和终端用户环境如何共同影响白内障手术设备的采用模式和投资重点。首先，从产品类型检验，产品线呈现连续性，涵盖了从飞秒雷射系统等高价平台到耗材和功能主机等各个方面。人工水晶体在这一频谱中扮演着核心角色，并进一步细分为：用于优化影像品质的非球面设计、用于扩大功能视野的景深晶状体、仍然是实用预设选择的单焦点晶状体、旨在摆脱眼镜的多焦点解决方案以及用于散光镜片的散光矫正晶状体。每个子类别都提出了不同的临床训练要求，并影响术后患者满意度指标。

美洲、欧洲、中东和非洲以及亚太地区在报销模式、手术量和基础设施方面的区域差异如何影响医疗设备策略？

在全球白内障生态系中，区域趋势仍是决定医疗设备分销策略和商业化方式的主要因素。在美洲，私人保险公司的积极参与，以及广泛的门诊手术中心网络，催生了对具备高效处理、可预测结果和完善售后服务的医疗设备的需求。同时，美洲的医疗机构通常要求医疗器材能够相容于整合平台，并提供清晰的临床和经济论证，以支持其资本投资决策。在欧洲、中东和非洲，法规环境和报销模式因地区而异。虽然欧洲部分地区正在快速采用高端晶体和雷射平台，但其他市场则优先考虑成本效益和公共采购管道。在这些地区，集中采购机制和国家临床指引对医疗器材的推广应用时间有显着的影响。

成熟平台营运商、镜片创新者和软体颠覆者之间的竞争动态和策略行动，塑造了临床应用和商业性竞争力。

白内障治疗设备领域的企业级发展趋势呈现出多元化的特点，既有成熟的平台供应商，也有专注于软体驱动的手术规划和耗材优化的敏捷型新兴参与企业。传统上提供全平台解决方案的成熟企业，利用其现有基础设施，透过模组化升级、服务合约和培训包提升销售方式，深化与临床机构的合作关係，并确保持续的收入来源。同时，专业的人工水晶体开发者则凭藉光学工程、先进材料科学以及临床证据，在目标患者群体中展现出显着的屈光优势，从而实现差异化竞争。

为加速技术采用、确保采购优势、加强供应链和临床支援能力提供切实可行的策略建议。

对于致力于将洞察转化为实际成果的产业领导者而言，一系列切实可行的建议将加速临床应用，增强供应链韧性，并优化商业性定位。首先，透过优先考虑能够减少术中变异性、改善患者报告结果并融入现有手术流程的功能，使产品开发与检验的临床需求保持一致。这将使製造商能够更清晰地向外科医生和采购委员会传达其价值提案。其次，要认识到单例手术总成本和耗材物流是采购决策的关键因素，并建立弹性价格设定和服务模式，以适应门诊手术中心、医院和专科诊所的经济特征。

调查方法，将对临床医生和采购负责人的初步调查与二手证据的整合以及严格的交叉检验程序相结合。

本报告的调查方法结合了系统性的初步研究和二手证据的整合，以确保得出可靠且可操作的结论。初步调查方法包括对执业眼科医师、医院和门诊手术中心的采购经理以及负责平台整合的设备工程师进行结构化访谈。此外，还对大型手术中心进行了现场考察，并咨询了监管专家，以检验设备的批准状态和上市后要求。这些资讯来源的数据与同行评审文献、临床结果註册研究和医疗设备附加檔进行了交叉比对，以检验技术声明和性能差异。

整合临床创新、营运适应性和供应链韧性，以确保白内障治疗的可持续应用和竞争地位。

总之，白内障手术医疗设备正处于一个转折点，技术创新、医疗服务分散化和地缘政治因素的共同作用，正在影响临床实践和商业策略。高精度雷射、先进的人工水晶体光学技术和数位化手术规划正在拓展患者可获得的治疗效果范围，而门诊治疗模式的转变则凸显了处理能力、器械相容性和耗材物流的重要性。同时，贸易政策趋势也凸显了全球供应链的脆弱性以及本地生产和弹性采购安排的策略价值。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 白内障手术设备市场：依产品类型划分

  • 飞秒雷射系统
  • 人工水晶体
    • 非人工水晶体
    • 景深扩展型人工水​​晶体
    • 单焦点人工水晶体
    • 多焦点人工水晶体
    • 散光人工水晶体
  • 眼用黏弹性装置
  • 超音波超音波乳化装置
  • 外科耗材

第九章 白内障手术设备市场：依技术划分

  • 囊外白内障摘除术
  • 飞秒雷射辅助
    • 弧形切口
    • 关节囊切开术
    • 晶状体碎裂
  • 手作小切口法
  • 法科姆

第十章：白内障手术设备市场：依最终用户划分

  • 门诊手术中心
  • 眼科研究所
  • 医院
  • 眼科诊所

第十一章 白内障手术设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 白内障手术设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 白内障手术设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国白内障手术设备市场

第十五章 中国白内障手术设备市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Essilor International SA
  • HAAG-Streit Holding AG
  • HOYA Surgical Optics, Inc.
  • Johnson & Johnson Vision Care, Inc.
  • Lenstec, Inc.
  • NIDEK Co., Ltd.
  • PhysIOL SA
  • Rayner Intraocular Lenses Limited
  • STAAR Surgical Company
  • Topcon Corporation
  • Ziemer Ophthalmic Systems AG
Product Code: MRR-433AB1DC28B7

The Cataract Surgery Devices Market was valued at USD 8.50 billion in 2025 and is projected to grow to USD 9.18 billion in 2026, with a CAGR of 8.36%, reaching USD 14.93 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.50 billion
Estimated Year [2026] USD 9.18 billion
Forecast Year [2032] USD 14.93 billion
CAGR (%) 8.36%

Framing the evolving cataract surgery device landscape in the context of clinical innovation, care setting shifts, and procurement imperatives

Cataract surgery devices occupy a pivotal position at the intersection of surgical innovation, demographic need, and healthcare delivery evolution. Over the past decade the field has advanced from reliance on conventional phacoemulsification and monofocal lenses toward a more diverse set of options that aim to improve refractive outcomes, reduce recovery times, and expand the settings in which procedures can be safely performed. These advances have been driven by parallel progress in imaging, laser precision, intraocular lens design, and consumables engineered to preserve ocular tissue and optimize intraoperative handling.

Consequently, clinical teams, procurement leaders, and device manufacturers are confronting a landscape that rewards interoperability, predictable supply chains, and a clear value proposition tied to clinical outcomes. As care pathways migrate from centralized hospitals to ambulatory surgery centers and specialty eye clinics, device selection increasingly reflects procedural throughput, compatibility with existing platforms, and support for emerging refractive technologies. In this context, a careful synthesis of device capabilities, regulatory trajectories, and end-user preferences is essential to inform purchasing strategies, clinical adoption, and product development roadmaps.

How precision lasers, diversified intraocular lens architectures, and care delivery decentralization are redefining clinical practice and supplier strategy

The cataract surgery device landscape is undergoing several transformative shifts that are reshaping clinical protocols, vendor strategies, and investment priorities. First, precision-guided femtosecond laser systems are altering the role of manual maneuvers by enabling more reproducible capsulotomies and targeted arcuate incisions, which in turn influence the selection of premium intraocular lenses and the expectation of refractive outcomes. In parallel, intraocular lens design has diversified beyond monofocal optics to include extended depth of focus, multifocal, toric, and advanced aspheric profiles, thereby broadening the patient populations and reimbursement conversations around premium care.

Simultaneously, the operational footprint of cataract care is shifting toward ambulatory surgery centers and high-volume ophthalmology clinics where throughput and device compatibility matter as much as instrument performance. This decentralization encourages device makers to prioritize modular systems, streamlined consumable logistics, and training packages that reduce variability in surgical results. Finally, digital integration-ranging from perioperative imaging to surgical planning software and interoperability with electronic health records-is emerging as a differentiator. Taken together, these shifts favor suppliers who can demonstrate clinical advantage, economic clarity, and an ability to integrate seamlessly into diverse care pathways.

Examining the operational and procurement consequences of U.S. tariff measures in 2025 and their implications for device sourcing and clinical adoption

Recent tariff actions and the broader trade policy environment in the United States in 2025 have created material reverberations across supply chains for cataract surgery devices, prompting manufacturers and providers to reassess sourcing strategies and cost structures. Because many devices and key components are manufactured across multiple geographies, incremental import levies have initiated a cascade of responses: some suppliers absorbed costs temporarily to preserve market access, others shifted procurement toward domestic or tariff-exempt suppliers, and a subset accelerated localization of critical subassemblies. As a result, purchasing timelines and vendor negotiations incorporated more explicit contingency clauses and near-term risk assessments.

Beyond direct cost implications, tariffs have influenced clinical adoption pathways by altering the relative price of premium intraocular lenses, femtosecond laser modules, and high-end phacoemulsification consoles. Healthcare systems pursuing predictable budgeting placed higher value on multi-year service agreements and bundled pricing, while ambulatory centers emphasized total cost per case and consumable availability. Importantly, regulatory alignment and expedited customs processes emerged as operational levers; manufacturers that demonstrated robust compliance documentation, local warehousing, and rapid replacement capability gained competitive advantage. Looking forward, these dynamics are likely to persist unless trade policies stabilize, underscoring the need for diversified supplier relationships and transparent price modeling within procurement strategies.

Detailed segmentation insights showing how product types, technology workflows, and care settings determine adoption patterns, training needs, and procurement priorities

Critical segmentation insights reveal how product design, procedural technology, and end-user setting jointly shape adoption patterns and investment priorities in cataract surgery devices. First, examining product type shows a continuum from high-capital platforms like femtosecond laser systems to consumables and phaco consoles. Intraocular lenses occupy a central role within this spectrum and further differentiate into aspheric designs aimed at image quality optimization, extended depth of focus lenses that broaden functional vision, monofocal lenses that remain the pragmatic default, multifocal solutions intended for spectacle independence, and toric lenses that address astigmatism correction. Each subcategory imposes distinct clinical training requirements and influences postoperative patient satisfaction metrics.

Turning to technology-based segmentation, there is a clear divide between extracapsular cataract extraction methods and more contemporary approaches such as femtosecond laser assisted surgery, manual small incision techniques, and phacoemulsification. Within femtosecond-assisted workflows, procedural modules like arcuate incisions for astigmatism management, capsulotomy for consistent lens centration, and lens fragmentation for reduced phaco energy are driving complementary device purchases and procedural standardization. Finally, end-user segmentation demonstrates differentiated purchasing priorities: ambulatory surgery centers and ophthalmology clinics often prioritize throughput, instrument footprint, and consumable logistics; eye institutes focus on research-grade versatility and clinical trial readiness; hospitals emphasize breadth of service and cross-specialty integration. Together, these segmentation axes indicate that successful commercial strategies must align product modularity, training support, and service models with the unique operational realities of each care setting.

How regional reimbursement models, surgical volumes, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific shape device strategies

Regional dynamics remain a primary determinant of device distribution strategies and commercialization approaches across the global cataract ecosystem. In the Americas, strong private payer participation combined with an extensive network of ambulatory surgery centers creates demand for devices that deliver throughput efficiency, predictable outcomes, and strong post-sale service. Conversely, institutional purchasing in the Americas often demands integrated platform compatibility and clear clinical-economic rationale to support capital investment decisions. Moving to Europe, Middle East & Africa, the region exhibits heterogenous regulatory environments and reimbursement models, with parts of Europe demonstrating rapid uptake of premium lenses and laser platforms while other markets prioritize cost-effectiveness and public procurement channels. In these territories, centralized procurement mechanisms and national clinical guidelines significantly influence adoption timelines.

Asia-Pacific presents a complex mix of high-volume cataract programs, rapidly modernizing private healthcare sectors, and regions where affordability remains the primary constraint. In several Asia-Pacific markets, the combination of high surgical volume and growing middle-class demand is spurring investment in both scalable phaco systems and premium IOL options, but suppliers must tailor service models and consumable pricing to local reimbursement realities. Across all regions, common threads include the rising importance of training ecosystems, supply chain resilience, and regulatory agility. Manufacturers that adapt regional go-to-market strategies to the local balance between cost, outcome expectations, and infrastructure capacity will be better positioned to capture diverse growth opportunities.

Competitive dynamics and strategic behaviors among platform incumbents, lens innovators, and software disruptors shaping clinical adoption and commercial advantage

Company-level dynamics in the cataract devices space are characterized by a combination of incumbent platform providers, specialized lens innovators, and agile newcomers focused on software-enabled surgical planning and consumables optimization. Incumbents that have historically delivered full-platform solutions are leveraging installed bases to upsell modular upgrades, service agreements, and training packages, thereby deepening clinical relationships and securing recurring revenue streams. At the same time, specialized intraocular lens developers are differentiating through optical engineering, premium material science, and clinical evidence that demonstrates distinct refractive advantages for targeted patient cohorts.

Newer entrants and medtech scale-ups are challenging traditional boundaries by introducing interoperable planning software, digital analytics for refractive outcomes, and supply chain innovations that reduce per-case costs. Strategic partnerships and distribution agreements remain preferred routes to accelerate market access, particularly for companies seeking to enter highly regulated markets or to expand hospital networks. Moreover, organizations that invest in robust clinical education programs and outcome registries tend to build stronger clinician advocacy and faster uptake of newer technologies. Ultimately, competitive advantage accrues to companies that align product innovation with demonstrable clinical benefit, flexible commercial models, and proven post-sale support.

Practical strategic recommendations to accelerate technology adoption, secure procurement advantage, and enhance supply chain and clinical support capabilities

For industry leaders seeking to translate intelligence into impact, a set of actionable recommendations can expedite clinical adoption, strengthen supply chain resilience, and optimize commercial positioning. First, align product development with validated clinical needs by prioritizing features that reduce intraoperative variability, improve patient-reported outcomes, and integrate into existing surgical workflows. By doing so, manufacturers will make the value proposition clearer to both surgeons and procurement committees. Second, develop flexible pricing and service models that accommodate the distinct economics of ambulatory surgery centers, hospitals, and specialty clinics, recognizing that total cost per case and consumable logistics are frequently decisive in purchase decisions.

Additionally, mitigate trade and regulatory risk by diversifying supplier networks and establishing localized inventory buffers in high-demand regions. Investing in clinician education and comprehensive outcome tracking provides a dual benefit: it accelerates evidence generation needed for premium device adoption and strengthens post-market surveillance. Finally, pursue interoperability through open standards for surgical planning and documentation, which will enhance compatibility with hospital IT systems and reduce barriers to adoption. Taken together, these steps create a practical roadmap for improving market receptivity while reducing operational friction for both providers and manufacturers.

Methodological framework combining primary clinician and procurement engagement with secondary evidence synthesis and rigorous cross-validation procedures

The research methodology underpinning this report combines systematic primary engagement with secondary evidence synthesis to ensure robust, actionable insights. Primary methods included structured interviews with practicing ophthalmic surgeons, procurement leaders across hospitals and ambulatory centers, and device engineers responsible for platform integration. These engagements were complemented by site visits to high-volume surgical centers and consultations with regulatory specialists to verify device clearances and post-market requirements. Data from these sources were triangulated with peer-reviewed literature, clinical outcome registries, and device labeling to validate technical claims and performance differentials.

Analytical approaches encompassed qualitative thematic analysis of clinician priorities, supplier capability mapping, and scenario assessments to explore sensitivity to trade policy shifts and reimbursement changes. Quality assurance steps included cross-validation of interview findings, review of methodology by clinical advisors, and iterative refinement of assumptions through stakeholder feedback. Together, these methods produced a balanced view that integrates clinical judgment, operational realities, and regulatory context, enabling readers to derive practical implications for procurement, product development, and market entry strategies.

Integrating clinical innovation, operational adaptability, and supply chain resilience to secure sustainable adoption and competitive positioning in cataract therapy

In closing, cataract surgery devices are at an inflection point where technological innovation, care delivery decentralization, and geopolitical factors collectively influence clinical practice and commercial strategy. Precision lasers, advanced intraocular lens optics, and digital surgical planning are expanding the set of achievable patient outcomes, while shifts toward ambulatory settings elevate the importance of throughput, device compatibility, and consumable logistics. Concurrently, trade policy developments have underscored the vulnerability of global supply chains and the strategic value of localized manufacturing and flexible procurement arrangements.

Therefore, stakeholders who invest in evidence-based product differentiation, robust clinician education, and resilient supply ecosystems will be better equipped to navigate uncertainty and capitalize on opportunities. By synthesizing clinical priorities with operational constraints and regulatory considerations, decision-makers can craft strategies that promote sustainable adoption, improve patient outcomes, and strengthen competitive positioning in a rapidly evolving landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cataract Surgery Devices Market, by Product Type

  • 8.1. Femtosecond Laser Systems
  • 8.2. Intraocular Lenses
    • 8.2.1. Aspheric Iols
    • 8.2.2. Extended Depth Of Focus Iols
    • 8.2.3. Monofocal Iols
    • 8.2.4. Multifocal Iols
    • 8.2.5. Toric Iols
  • 8.3. Ocular Viscoelastic Devices
  • 8.4. Phacoemulsification Equipment
  • 8.5. Surgical Consumables

9. Cataract Surgery Devices Market, by Technology

  • 9.1. Extracapsular Cataract Extraction
  • 9.2. Femtosecond Laser Assisted
    • 9.2.1. Arcuate Incisions
    • 9.2.2. Capsulotomy
    • 9.2.3. Lens Fragmentation
  • 9.3. Manual Small Incision
  • 9.4. Phacoemulsification

10. Cataract Surgery Devices Market, by End User

  • 10.1. Ambulatory Surgery Centers
  • 10.2. Eye Institutes
  • 10.3. Hospitals
  • 10.4. Ophthalmology Clinics

11. Cataract Surgery Devices Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Cataract Surgery Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Cataract Surgery Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Cataract Surgery Devices Market

15. China Cataract Surgery Devices Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Abbott Laboratories
  • 16.6. Alcon, Inc.
  • 16.7. Bausch & Lomb Incorporated
  • 16.8. Carl Zeiss Meditec AG
  • 16.9. Essilor International S.A.
  • 16.10. HAAG-Streit Holding AG
  • 16.11. HOYA Surgical Optics, Inc.
  • 16.12. Johnson & Johnson Vision Care, Inc.
  • 16.13. Lenstec, Inc.
  • 16.14. NIDEK Co., Ltd.
  • 16.15. PhysIOL SA
  • 16.16. Rayner Intraocular Lenses Limited
  • 16.17. STAAR Surgical Company
  • 16.18. Topcon Corporation
  • 16.19. Ziemer Ophthalmic Systems AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CATARACT SURGERY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CATARACT SURGERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ASPHERIC IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTENDED DEPTH OF FOCUS IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MONOFOCAL IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MULTIFOCAL IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TORIC IOLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OCULAR VISCOELASTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY SURGICAL CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EXTRACAPSULAR CATARACT EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY ARCUATE INCISIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY CAPSULOTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY LENS FRAGMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY MANUAL SMALL INCISION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY PHACOEMULSIFICATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY EYE INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 80. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 81. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 87. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 88. LATIN AMERICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE, MIDDLE EAST & AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 129. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 131. GCC CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CATARACT SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 158. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA CATARACT SURGERY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY INTRAOCULAR LENSES, 2018-2032 (USD MILLION)
  • TABLE 166. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY FEMTOSECOND LASER ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CATARACT SURGERY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)